Press
Writing a story about Ro or one of our services? Contact us at [email protected]
Ro is a direct-to-patient healthcare company focused on goal oriented healthcare
Ro is the only company in the US that integrates telehealth, pharmacy, at-home testing, labs and diagnostics
Ro has helped a patient in nearly every single county in the country
In the news
Fast Company
June 4, 2024
This prescription gummy was designed to treat erectile dysfunction
Bloomberg Television
February 1, 2024
Ro CEO Sees Unprecedented Demand for Weight Loss Drugs
The Wall Street Journal
November 23, 2023
He Sold Burritos Out of His Apartment Window. Now He’s Running a $7 Billion Startup.
Good Morning America
October 17, 2023
How patients navigate insurance coverage for weight-loss medications
Forbes Talks
June 30, 2023
Ro CEO Says US Must 'Overhaul' Healthcare System After Shortage of 'Life-Changing' Weight Loss Drug
The Wall Street Journal
April 4, 2023
Hype Around Weight-Loss Drugs Shows No Signs of Abating. Neither Do the Ads.
CNBC
January 24, 2023
Ro CEO on Ro Body, the company's first insurance-based offering
Bloomberg
February 15, 2022
Ro Funding Round Brings Health Startup’s Valuation to $7 Billion
Press releases
August 13, 2024
Ro launches the GLP-1 Insurance Coverage Checker
July 24, 2024
Ro Welcomes Obesity Research Expert David B. Allison to its Advisory Board
May 29, 2024
Ro launches the GLP-1 Supply Tracker
May 1, 2024
Ro Introduces the Ro Operating System (ro.OS)
December 13, 2023
Zepbound™ (Tirzepatide) Now Available Through Ro Body Program
April 26, 2023
People with Obesity Share Perspectives on Weight Loss and GLP-1 Medications in Survey from Ro and the Obesity Action Coalition
January 20, 2023
Ro Launches Weight Loss Program With GLP-1 Medications, Lab Testing, 1:1 Coaching, and Personalized Provider Care
November 30, 2022
New Ro App Helps Patients Conveniently and Effectively Achieve their Health Goals
October 6, 2022
Ro Announces Agreement with the NIH National Institute on Aging
February 15, 2022
Ro Raises $150 Million from Existing Investors to Expand its Direct-to-Patient Healthcare Model
June 30, 2021
Ro Acquires Kit to Expand At-Home Diagnostics and Preventative Care Capabilities
May 19, 2021
Ro acquires Modern Fertility to accelerate its leadership in women's health
April 27, 2021
Ro Launches Exclusive Roman OTC Products in First National Retail Collaboration
March 23, 2021
Ro Raises $500 Million in Series D Funding to Expand its Vertically Integrated Primary Care Platform
March 3, 2021
Ro works with New York State's Department of Health to launch first-of-its-kind in-home COVID-19 vaccination program
January 13, 2021
Ro and Gauss Partner to Offer Rapid, At-Home COVID-19 Testing Nationwide
December 8, 2020
Ro Acquires Workpath to Offer In-Home Care Services Nationwide
December 8, 2020
Ro and Quest Diagnostics Partner to Offer Lab Testing Through Ro's Vertically Integrated Primary Care Platform
July 27, 2020
Ro Raises $200 Million in Series C Funding to Expand its Patient-Centric Healthcare System
Clinical research from Ro
Journal of Fertility & Sterility
Contraceptive-specific anti-mullerian hormone values in reproductive-age women: a population study of 42,684 women
Journal of Medical Internet Research
Characteristics and Weight Loss Practices From a Cohort of 20,000 Patients Using Direct-to-Consumer Telehealth
Special Issue: Abstracts from the 40th Annual Meeting of the Obesity Society at Obesityweek®
Experiences of Stigma Among People Seeking Care for Obesity Compared to Other Stigmatized Conditions
Telemedicine and e-Health
The Relationship Between Broadband Speeds, Device Type, Demographic Characteristics, and Care-Seeking Via Telehealth
Frontiers in Public Health
Novel in-home COVID-19 vaccination program for vulnerable populations using public-private collaboration
American Journal of Obstetrics & Gynecology
Anti-Müllerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals
Journal of Medical Internet Research
Evaluating the Quality of Asynchronous Versus Synchronous Virtual Care in Patients With Erectile Dysfunction: Retrospective Cohort Study